SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ALCOBRA LTD.
(NQSC:ADHD Last Sale: 16.21 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (ADHD : $16.21)
$180 million Market Cap at September 12, 2013
Drugs SubIndustry up .00% / Health Industry up .00% Today

Tel Aviv, Research Report Earnings Snapshot - Last 11/17/18
Israel Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


emerging biopharmaceutical company primarily focused on the development and commercialization of our proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder, or ADHD.
Historical Charts    Technical Analysis
No Historical Data available for ADHD

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ADHD $16.21 $ 0 $15.53 $16.749 17,801 $6.5 $16.749 11,126
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $180,352

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex